EP 287: GLP-1 Is a Disruption Retailers Aren’t Ready For

We'd love to have your feedback and ideas for future episodes of Retail Unwrapped. Just text us!The fastest-growing consumer behavior shift isn't driven by a trend, a digital platform, or a fickle generation: it’s a weight loss drug. GLP-1 adoption is accelerating so fast that Ozempic is outpacing iPhone adoption curves in the same timeframe.  Retailers (both grocery and apparel) are treating this trend as a passing diet fad. Join Shelley with Liza Amlani, Founder of Retail Strategy Group and Ali Furman, PwC's Consumer Markets Industry Leader as they challenge retailers to confront how to serve customers when body sizes change faster than the systems built to serve them. One outlook? Up to 400 million apparel units could be misaligned with actual demand by 2027, with retailers facing up to a $5 billion margin hit from oversized inventory, returns, and markdowns. Listen and learn why the GPT craze is an opportunity, not a transaction, for retailers who build trust with consumers whose bodies, wardrobes, and identities are all in flux. That loyalty will outlast the drug itself.Special Guests: Liza Amlani, Principal and Founder, Retail Strategy Group and Ali Furman, Consumer Markets Industry Leader, PwCFor more strategic insights and compelling content, visit TheRobinReport.com, where you can read, watch, and listen to content from Robin Lewis and other retail industry experts, and be sure to follow us on LinkedIn and Twitter.